Business Description
Interpace Biosciences Inc
NAICS : 541380
SIC : 8099
ISIN : US46062X2045
Description
Interpace Biosciences Inc is engaged in the life sciences industry. It provides molecular diagnostics, bioinformatics, and pathology services for the evaluation of the risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. The company develops and commercializes genomic tests and related first-line assays principally focused on the early detection of patients with indeterminate biopsies and at high risk of cancer using the latest technology. It operates under one segment which is the business of developing and selling diagnostic clinical services.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.37 | |||||
| Equity-to-Asset | -4.4 | |||||
| Debt-to-Equity | -0.22 | |||||
| Debt-to-EBITDA | 14.7 | |||||
| Interest Coverage | 0.83 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -22.41 | |||||
| Beneish M-Score | -2.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.1 | |||||
| 3-Year EBITDA Growth Rate | 54.8 | |||||
| 3-Year EPS without NRI Growth Rate | 39.9 | |||||
| 3-Year FCF Growth Rate | 28.1 | |||||
| 3-Year Book Growth Rate | -134.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.44 | |||||
| 9-Day RSI | 47.01 | |||||
| 14-Day RSI | 49.01 | |||||
| 6-1 Month Momentum % | -26.36 | |||||
| 12-1 Month Momentum % | -9.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.93 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.41 | |||||
| Days Inventory | 29.14 | |||||
| Days Sales Outstanding | 48.63 | |||||
| Days Payable | 35.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.1 | |||||
| Shareholder Yield % | -35.35 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.35 | |||||
| Operating Margin % | 2.33 | |||||
| Net Margin % | -40.79 | |||||
| FCF Margin % | -6.39 | |||||
| ROA % | -98.56 | |||||
| ROIC % | 13.95 | |||||
| ROC (Joel Greenblatt) % | -31.4 | |||||
| ROCE % | -45.96 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.13 | |||||
| EV-to-EBIT | -17.05 | |||||
| EV-to-EBITDA | 14.47 | |||||
| EV-to-Revenue | 0.36 | |||||
| EV-to-Forward-Revenue | 0.44 | |||||
| EV-to-FCF | -5.55 | |||||
| Earnings Yield (Greenblatt) % | -5.87 | |||||
| FCF Yield % | -46.51 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IDXG
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Interpace Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 37.373 | ||
| EPS (TTM) ($) | -3.6 | ||
| Beta | 0.91 | ||
| Volatility % | 214.2 | ||
| 14-Day RSI | 49.01 | ||
| 14-Day ATR ($) | 0.108726 | ||
| 20-Day SMA ($) | 1.11837 | ||
| 12-1 Month Momentum % | -9.52 | ||
| 52-Week Range ($) | 0.51 - 3.54 | ||
| Shares Outstanding (Mil) | 4.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Interpace Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Interpace Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Interpace Biosciences Inc Frequently Asked Questions
What is Interpace Biosciences Inc(IDXG)'s stock price today?
The current price of IDXG is $1.15. The 52 week high of IDXG is $3.54 and 52 week low is $0.51.
When is next earnings date of Interpace Biosciences Inc(IDXG)?
The next earnings date of Interpace Biosciences Inc(IDXG) is .
Does Interpace Biosciences Inc(IDXG) pay dividends? If so, how much?
Interpace Biosciences Inc(IDXG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers